Company / Tangible Book Value per Share
Royalty Pharma plc Tangible Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$14.58
FY2025
5-year range
$14.58 / $26.36
FY2021-FY2025
Trend
-38.3%
vs FY2024
Sector context
#37 of 209
Health Care
What the data says
Royalty Pharma plc's tangible book value per share of $14.58 is higher than 82% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has declined for 3 consecutive years, from $26.36 in FY2022 to $14.58 in FY2025.
Based on SEC 10-K filings.
14.58 in FY2025 with a 5-year CAGR of +3.8%. Top quartile in the Health Care sector.
Declined from $24.31 to $14.58 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -17.9%
- 5-Year CAGR
- +3.8%
- 10-Year CAGR
- -
Sector benchmark
-87.8% below sector average
Key checks
Key Insights
- Royalty Pharma plc's tangible book value per share has declined for 3 consecutive years.
- In FY2025, tangible book value per share decreased 38.3% year-over-year.
- Ranks #37 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.58 | -38.3% |
| FY2024 | $23.61 | -2.9% |
| FY2023 | $24.31 | -7.8% |
| FY2022 | $26.36 | +61.1% |
| FY2021 | $16.36 | +34.9% |
| FY2020 | $12.12 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026